Diagnosis and treatment of right ventricular dysfunction in congenital heart disease

Autor: Daniel Bernstein, Pieter De Meester, Werner Budts, Martin Koestenberger, Alexander Van De Bruaene, Béatrice Santens, Georg Hansmann, Michele D'Alto, Sushma Reddy
Rok vydání: 2020
Předmět:
PULMONARY ARTERIAL-HYPERTENSION
medicine.medical_specialty
Cardiac & Cardiovascular Systems
Heart disease
SYSTEMIC RIGHT VENTRICLE
Hemodynamics
systemic right ventricular
CARDIAC TROPONIN-T
030204 cardiovascular system & hematology
Review Article on Right Ventricular Dysfunction
03 medical and health sciences
0302 clinical medicine
ANGIOTENSIN RECEPTOR BLOCKADE
HIGH-SENSITIVITY TROPONIN
Internal medicine
heart failure (HF)
Medicine
cardiovascular diseases
030212 general & internal medicine
AMERICAN SOCIETY
EUROPEAN ASSOCIATION
Science & Technology
Troponin T
treatment of heart failure
business.industry
Congenital heart disease (CHD)
GROWTH-DIFFERENTIATION FACTOR-15
medicine.disease
CORRECTED TRANSPOSITION
Blood pressure
medicine.anatomical_structure
BRAIN NATRIURETIC PEPTIDE
Ventricle
Heart failure
Cardiovascular System & Cardiology
Cardiology
right ventricular dysfunction
GDF15
Cardiology and Cardiovascular Medicine
business
Life Sciences & Biomedicine
Perfusion
Zdroj: Cardiovasc Diagn Ther
ISSN: 2223-3660
2223-3652
DOI: 10.21037/cdt-20-370
Popis: Right ventricular (RV) function is important for clinical status and outcomes in children and adults with congenital heart disease (CHD). In the normal RV, longitudinal systolic function is the major contributor to global RV systolic function. A variety of factors contribute to RV failure including increased pressure- or volume-loading, electromechanical dyssynchrony, increased myocardial fibrosis, abnormal coronary perfusion, restricted filling capacity and adverse interactions between left ventricle (LV) and RV. We discuss the different imaging techniques both at rest and during exercise to define and detect RV failure. We identify the most important biomarkers for risk stratification in RV dysfunction, including abnormal NYHA class, decreased exercise capacity, low blood pressure, and increased levels of NTproBNP, troponin T, galectin-3 and growth differentiation factor 15. In adults with CHD (ACHD), fragmented QRS is independently associated with heart failure (HF) symptoms and impaired ventricular function. Furthermore, we discuss the different HF therapies in CHD but given the broad clinical spectrum of CHD, it is important to treat RV failure in a disease-specific manner and based on the specific alterations in hemodynamics. Here, we discuss how to detect and treat RV dysfunction in CHD in order to prevent or postpone RV failure. ispartof: CARDIOVASCULAR DIAGNOSIS AND THERAPY vol:10 issue:5 pages:1625-1645 ispartof: location:China status: published
Databáze: OpenAIRE